[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-515745-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-515745-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","hematopoietic-and-lymphoid-neoplasm-coding-manual-effective-with-cases-diagnosed-112010-and-forward","Hematopoietic and Lymphoid Neoplasm Coding Manual - Effective with Cases Diagnosed 1/1/2010 and Forward","","Hematopoietic and Lymphoid Neoplasm Coding Manual provides standardized coding rules for cancer registrars to identify, abstract, and code hematopoietic and lymphoid neoplasm cases diagnosed on or after January 1, 2010. It explains how to follow manual instructions for multiple primaries, histology, and primary site, and clarifies that the rules are for cancer registries rather than physician use. The manual references training via SEER*Educate, directs reporting under specific guidelines, and notes that later cases must use the current version on the SEER website.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/healthcare/","Healthcare",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/hematopoietic-and-lymphoid-neoplasm-coding-manual-effective-with-cases-diagnosed-112010-and-forward/515745/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/hematopoietic-and-lymphoid-neoplasm-coding-manual-effective-with-cases-diagnosed-112010-and-forward/515745.png","ImageObject",300,407,{"name":42,"@type":43},"supergirl","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-29","2026-10-06",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Who is this manual intended for, and what is its purpose?","Question",{"text":63,"@type":64},"The manual is dedicated to cancer registrars worldwide who identify, abstract, and code cancer data. It provides standardized instructions for coding hematopoietic and lymphoid neoplasms.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"When do these rules take effect for case diagnosis?",{"text":68,"@type":64},"The manual’s rules are effective with cases diagnosed January 1, 2010 and forward. For diagnoses in 2010+, registrars should use the current version on the SEER website.",{"name":70,"@type":61,"acceptedAnswer":71},"Can the manual rules differ from what physicians indicate in the record?",{"text":72,"@type":64},"Yes. The manual guidance may or may not agree with what a physician indicates in the patient record, and physician interpretation can affect reportability, diagnostic confirmation, or primary site only as addressed in the specific coding instructions.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},515745,1791431557,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":108,"slug":109},7,40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":112,"show_sort_weight":113,"slug":114},8,"Research & Report",30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":107,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":4},962088121634,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","Hematopoietic and Lymphoid Neoplasm Coding Manual  \nEffective with Cases Diagnosed 1/1/2010 and Forward  \nPublished September 2026  \nEditors: Jennifer Ruhl, MSHCA, RHIT, CCS, ODS-C (NCI SEER)  \nCarolyn Callaghan, ODS-C (SEER Seattle Registry) Tiffany Janes, ODS-C (SEER Seattle Registry)  \nSuzanne Adams, BS, ODS-C (IMS)  \nSuggested citation: Ruhl J, Callaghan C, Janes T, Adams S (September 2026) . Hematopoietic and Lymphoid  \nNeo plasm Coding Manual . National Cancer Institute, Bethesda, MD, 2026.  \nIn Remembrance  \nSEER would like to take this opportunity to remember our colleague Carol Hahn Johnson, who worked for the SEER program, retired in 2012 and died December 2023. Carol was the brains and power behind the development of the Hematopoietic Manual and Database. Even after her retirement in 2012, she continued to provide assistance when asked and was instrumental in Jennifer Ruhl taking over managing the Hematopoietic manual and database.  \nIn Appreciation  \nSEER would also like to take this opportunity to acknowledge the contributions of Lois Dickie, ODS-C and Peggy Adamo, ODS-C to the development of the Hematopoietic Manual and Database in 2010.  \nNCI SEER gratefully acknowledges the dedicated work of Drs. Charles Platz and Graca Dores since the inception of the Hematopoietic project. We deeply appreciate their willingness to serve as advisors for the rules within this manual for many years. The quality of this Hematopoietic project is directly related to their commitment.  \nNCI SEER would also like to acknowledge the following individuals who continue to provide support to all the SEER products through their working on SEER*Educate.  \n• Carolyn Callaghan, ODS-C (SEER Seattle Registry)  \n• Tiffany Janes, ODS-C (SEER Seattle Registry)  \nTo our wonderful SEER Registries, many of whom provided excellent feedback on the Hematopoietic manual, we would like to express our sincere thanks. Their continued support of our efforts to provide comprehensive manuals for the registry community are greatly appreciated.  \nWe would also like to give a special thanks to the following individuals at Information Management Services, Inc. (IMS) who provide us with document support and web development.  \n• Sean Brennan, BS  \n• Asya Melkonyan, MA  \n• Paul Stephenson, BS  \n• Jacob Tomlinson, BS  \nDedication  \nThe Hematopoietic and Lymphoid Neoplasm Coding Manual (Heme manual) and the companion Hematopoietic and Lymphoid Neoplasm Database (Heme DB) are dedicated to the hard-working cancer registrars across the world who meticulously identify, abstract, and code cancer data. Cancer registrars are the foundation for statewide, provincial, territorial, national, and international cancer surveillance programs which support cancer prevention and cancer control efforts worldwide.  \nA huge thank you to the registrars who submitted questions to Ask a SEER Registrar which resulted in changes to the manual and database.  \nEducation  \nSEER*Educate provides training on how to use the Heme Manual and DB.  \nQuestions about the Hematopoietic Manual and Database are to be sent to Ask a SEER Registrar-SEER Registrars. Under Reporting Guidelines choose Hematopoietic Rules (database and manual)  \nUse this manual and the corresponding database to abstract and code cases diagnosed January 1, 2010, and forward.  \nPlease note that these rules are for cancer registries and are not followed by physicians.  \n• Follow the rules as stated in this manual and abstract the number of primaries based on the rules. These rules were developed to provide standardized instructions on how to code multiple primaries, histology and primary site across the United States and Canada.  \n• This may, or may not, agree with what the physician indicates in the patient record.  \n• Physician interpretation can sometimes factor into determining reportability, diagnostic confirmation, or primary site; this is addressed in the specific coding instructions for those sections.  \nFor cases diagnosed 2","cbCail9tKBcHogNZ","https://ap.wps.com/l/cbCail9tKBcHogNZ","pdf",1758702,109,"English","# Introduction of ICD-O-4\n# Introduction and Background\n# Leukemias and Lymphomas\n# Lymph","[{\"question\":\"Who is this manual intended for, and what is its purpose?\",\"answer\":\"The manual is dedicated to cancer registrars worldwide who identify, abstract, and code cancer data. It provides standardized instructions for coding hematopoietic and lymphoid neoplasms.\"},{\"question\":\"When do these rules take effect for case diagnosis?\",\"answer\":\"The manual’s rules are effective with cases diagnosed January 1, 2010 and forward. For diagnoses in 2010+, registrars should use the current version on the SEER website.\"},{\"question\":\"Can the manual rules differ from what physicians indicate in the record?\",\"answer\":\"Yes. The manual guidance may or may not agree with what a physician indicates in the patient record, and physician interpretation can affect reportability, diagnostic confirmation, or primary site only as addressed in the specific coding instructions.\"}]","Hematopoietic and Lymphoid Neoplasm Coding Manual - Effective with Cases Diagnosed 1/1/2010 and Forward | PDF",1791321743,275]